QuantaLife Closes $17.2M Series B Round to Back Upcoming Launch of Droplet Digital PCR Platform | GenomeWeb

By Ben Butkus

This article has been updated from a version posted Dec. 10 to include additional information and comments from a company official.

QuantaLife said late last week that it has closed a Series B financing round worth $17.2 million.

The company said that it plans to use the majority of the proceeds to ramp up its commercial operations in anticipation of the launch of its Droplet Digital PCR platform in the first half of 2011.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.